HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 2.89
Day range
kr 2.83 - kr 3.18
Year range
kr 2.83 - kr 8.21
Market cap
623.58M SEK
Avg Volume
961.36K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.34M | 853.04% |
Operating expense | 85.54M | -15.40% |
Net income | -81.21M | 10.85% |
Net profit margin | -1.52K | 90.65% |
Earnings per share | — | — |
EBITDA | -80.48M | 19.56% |
Effective tax rate | -2.63% | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 173.41M | -49.72% |
Total assets | 238.38M | -38.14% |
Total liabilities | 181.60M | 99.49% |
Total equity | 56.78M | — |
Shares outstanding | 94.60M | — |
Price to book | 4.82 | — |
Return on assets | -75.92% | — |
Return on capital | -90.65% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -81.21M | 10.85% |
Cash from operations | -55.40M | 28.64% |
Cash from investing | -1.00K | 99.96% |
Cash from financing | -3.86M | -21.97% |
Net change in cash | -60.19M | 27.38% |
Free cash flow | -31.69M | 27.37% |
About
CEO
Founded
2000
Website
Employees
57